Evidence map›Paper›PMID 31227872›Full record

Trial reportAnnals of hematology2019

Variants in ARID5B gene are associated with the development of acute lymphoblastic leukemia in Mexican children.

Adriana Reyes-León, Maribel Ramírez-Martínez, Diana Fernández-García, David Amaro-Muñoz, José Antonio Velázquez-Aragón, Consuelo Salas-Labadía, Marta Zapata-Tarrés, Liliana Velasco-Hidalgo, Norma López-Santiago, Mayra Ivette López-Ruiz and 6 more

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Annals of hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012-2016.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Adriana Reyes-LeónLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Colonia Insurgentes Cuicuilco, C.P. 04530, Mexico City, Mexico.
Maribel Ramírez-MartínezLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Colonia Insurgentes Cuicuilco, C.P. 04530, Mexico City, Mexico.
Diana Fernández-GarcíaLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Colonia Insurgentes Cuicuilco, C.P. 04530, Mexico City, Mexico.
David Amaro-MuñozLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Colonia Insurgentes Cuicuilco, C.P. 04530, Mexico City, Mexico.
José Antonio Velázquez-AragónLaboratorio de Biología Molecular, Instituto Nacional de Pediatría, Mexico City, Mexico.
Consuelo Salas-LabadíaLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Colonia Insurgentes Cuicuilco, C.P. 04530, Mexico City, Mexico.
Marta Zapata-TarrésServicio de Oncología, Instituto Nacional de Pediatría, Mexico City, Mexico.
Liliana Velasco-HidalgoServicio de Oncología, Instituto Nacional de Pediatría, Mexico City, Mexico.
Norma López-SantiagoServicio de Hematología, Instituto Nacional de Pediatría, Mexico City, Mexico.
Mayra Ivette López-RuizDepartamento de Oncología, Hospital de Especialidades Pediátricas de Tuxtla Gutiérrez, Tuxtla Gutiérrez, Chiapas,, Mexico.
Monica Anabell Malavar-GuadarramaDepartamento de Hematología, Hospital de Especialidades Pediátricas de Tuxtla Gutiérrez, Tuxtla Gutiérrez, Chiapas, Mexico.
Rocío Cárdenas-CardósServicio de Oncología, Instituto Nacional de Pediatría, Mexico City, Mexico.
Rogelio Paredes-AguileraServicio de Hematología, Instituto Nacional de Pediatría, Mexico City, Mexico.
Roberto Rivera-LunaSubdirección de Hemato-Oncología, Instituto Nacional de Pediatría, Mexico City, Mexico.
Michael DeanLaboratory of Translational Genomics, Division of Cancer Epidemiolgy & Genetics, National Cancer Institute, Bethesda, MD, USA.
Patricia Pérez-VeraLaboratorio de Genética y Cáncer, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Colonia Insurgentes Cuicuilco, C.P. 04530, Mexico City, Mexico. pperezvera@yahoo.com.ORCID http://orcid.org/0000-0001-5662-6991
Instituto Nacional de Pediatria · MXHospital de Especialidades · MXNational Cancer Institute · USUniversidad Insurgentes · MX

Funding

Single Nucleotide Polymorphisms in Cancer Related GenesZ01BC005652 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DEAN, MICHAEL · 1996 to 2008
$1.9M
Consejo Nacional de Ciencia y Tecnologia (CONACyT) Desarrollo Cientifico para Atender Problemas Nacionales 216163Fondos del Presupuesto Federal para la Investigación 085/2012Intramural NIH HHS Z01 BC005652Intramural Program of the National Cancer Institute 00
6 · The paper itself

Abstract

A high impact of ARID5B SNPs on acute lymphoblastic leukemia (ALL) susceptibility has been described in Hispanic children; therefore, it is relevant to know if they influence the high incidence of childhood-ALL in Mexicans. Seven SNPs (rs10821936, rs10994982, rs7089424, rs2393732, rs2393782, rs2893881, rs4948488) of ARID5B were analyzed in 384 controls and 298 ALL children using genomic DNA and TaqMan probes. The SNPs were analyzed for deviation of Hardy-Weinberg equilibrium; Fisher's exact test was used to compare the genotypic and allelic frequencies between controls and patients. The association between SNPs and ALL susceptibility was calculated, and haplotype and ancestry analyses were conducted. All SNPs were associated with ALL, pre-B ALL, and hyperdiploid-ALL susceptibility (p < 0.05). No association with T-ALL and gene fusions was found (p > 0.05). The seven SNPs were associated with risk of pre-B ALL in younger children; however, rs2393732, rs2393782, rs2893881, and rs4948488 were not associated with susceptibility in older children and adolescents. The CAG haplotype (rs10821936, rs10994982, rs7089424) was strongly associated with ALL risk in our population (p < 0.00001). The frequency of all risk alleles in our ALL, pre-B, and hyperdiploid-ALL patients was higher than that in Hispanic children reported. This is the first report showing the association between rs2393732, rs2393782, and rs4948488 with pre-B hyperdiploid-ALL children. The G allele at rs2893881 confers major risk for pre-B hyperdiploid-ALL in Mexican (OR, 2.29) than in Hispanic children (OR, 1.71). The genetic background of our population could influence the susceptibility to ALL and explain its high incidence in Mexico.

Indexed as

AllelesGenetic Predisposition to DiseaseHaplotypesPolymorphism, Single NucleotideChildChild, PreschoolDNA-Binding ProteinsFemaleHumansInfantMaleMexicoNeoplasm ProteinsPrecursor B-Cell Lymphoblastic Leukemia-LymphomaTranscription FactorsARID5B protein, humanDNA-Binding ProteinsNeoplasm ProteinsTranscription FactorsAcute lymphoblastic leukemiaARID5B geneMexican childrenSingle nucleotide polymorphismsSusceptibility

Identifiers

PMID31227872
PMCPMC11486264
OpenAlexW2907763064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.